Rheumatology News: FDA Advises Caution When IV Methotrexate-PPI Used Together

RA Guy Community News

Administration of a proton pump inhibitor with intravenous methotrexate may result in elevated serum levels of methotrexate, with toxic consequences, according to a statement issued on Dec. 21 by the Food and Drug Administration.

Case reports and published pharmacokinetic studies “suggest” that concomitant use of proton pump inhibitors (PPIs) with methotrexate, primarily high dose methotrexate, “may elevate and prolong serum levels of methotrexate and/or its metabolite hydroxymethotrexate, possibly leading to methotrexate toxicities,” the statement says.

Read More: http://www.rheumatologynews.com/single-view/fda-advises-caution-when-iv-methotrexate-ppi-used-together/2dc8f226f5.html